NRAS-selective inhibitor (Relay Therapeutics)

N/A

Report date: 2025/06/11 11:18:46
NME

Base Information

Drug NameNRAS-selective inhibitor (Relay Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGTPase NRas inhibitorsAnticancer protein kinase inhibitors
TargetsGTPase NRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRelay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRelay Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A